Makoto Kinoshita Selected Research

Autoimmune Diseases (Autoimmune Disease)

1/2023	Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder.
1/2022	High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD).
3/2013	Disease-association analysis of an inflammation-related feedback loop.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Kinoshita Research Topics

Disease

19	Schizophrenia (Dementia Praecox) 01/2021 - 04/2009
13	Inflammation (Inflammations) 01/2023 - 10/2003
9	Multiple Sclerosis 11/2022 - 08/2008
8	Neuromyelitis Optica (Devic's Disease) 01/2023 - 03/2009
8	Parkinson Disease (Parkinson's Disease) 01/2021 - 06/2003
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 08/2008
6	Atrial Fibrillation 01/2024 - 06/2021
6	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 09/2005
6	Myocardial Infarction 01/2013 - 12/2002
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2017 - 04/2009
5	Atherosclerosis 01/2013 - 03/2004
4	COVID-19 04/2024 - 01/2021
4	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 11/2016
4	Hearing Loss (Hearing Impairment) 04/2022 - 01/2013
4	Neoplasms (Cancer) 01/2022 - 12/2005
4	Thymoma (Thymic Carcinoma) 01/2022 - 11/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 06/2003
4	Necrosis 01/2012 - 10/2003
4	Hyperlipidemias (Hyperlipidemia) 08/2009 - 05/2002
3	Heart Failure 01/2024 - 10/2003
3	Aortic Rupture 08/2023 - 01/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 03/2013
3	Thrombosis (Thrombus) 10/2022 - 12/2002
3	Myasthenia Gravis 01/2022 - 06/2020
3	Pain (Aches) 08/2021 - 11/2009
3	Ischemia 02/2015 - 11/2009
3	Chronic Limb-Threatening Ischemia 01/2014 - 11/2009
3	Dyslipidemias (Dyslipidemia) 11/2012 - 01/2009
3	Myocarditis (Carditis) 07/2008 - 10/2003
2	Synucleinopathies 04/2024 - 06/2003
2	Aortic Aneurysm (Aneurysm, Aortic) 02/2023 - 01/2014
2	Aneurysm (Aneurysms) 02/2022 - 08/2017
2	Aortic Dissection 11/2021 - 08/2017
2	Nervous System Diseases (Neurological Disorders) 08/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 08/2021 - 01/2021
2	Treatment-Resistant Schizophrenia 01/2021 - 03/2017
2	Relapsing-Remitting Multiple Sclerosis 03/2020 - 01/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 08/2014
2	Neuroinflammatory Diseases 01/2019 - 10/2012
2	Wounds and Injuries (Trauma) 01/2018 - 04/2015
2	Encephalomyelitis (Myeloencephalitis) 12/2016 - 01/2011
2	Carotid Stenosis (Carotid Artery Stenosis) 02/2015 - 11/2014
2	Pathologic Constriction (Stenosis) 02/2015 - 07/2014
2	Parkinsonian Disorders (Parkinsonism) 01/2015 - 08/2013
2	Stroke (Strokes) 01/2015 - 01/2011
2	Ulcer 01/2014 - 11/2009
2	Aortic Intramural Hematoma 01/2014 - 09/2009
2	Coronary Stenosis (Coronary Artery Stenosis) 04/2013 - 02/2007

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2007
9	SeptinsIBA 01/2018 - 12/2005
7	AutoantibodiesIBA 01/2022 - 03/2009
6	CytokinesIBA 11/2022 - 10/2003
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2007
5	AntigensIBA 01/2022 - 03/2010
5	HomocysteineIBA 12/2016 - 06/2013
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
4	Immunoglobulin G (IgG)IBA 06/2022 - 03/2009
4	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 09/2014
4	Sirtuin 1IBA 02/2015 - 08/2014
4	oxidized low density lipoproteinIBA 11/2010 - 01/2004
3	Mitochondrial DNA (mtDNA)IBA 04/2022 - 04/2018
3	AntibodiesIBA 01/2022 - 06/2020
3	anti-aquaporin 4 autoantibodyIBA 08/2021 - 03/2010
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2017
3	C-Reactive ProteinIBA 02/2018 - 01/2014
3	CarbonIBA 02/2018 - 01/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2008
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2016 - 09/2014
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014 - 11/2009
3	CholesterolIBA 11/2010 - 01/2004
3	Lipoproteins (Lipoprotein)IBA 01/2009 - 04/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2008
2	InterferonsIBA 01/2023 - 01/2022
2	NucleotidesIBA 04/2022 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 08/2021 - 02/2015
2	AcidsIBA 01/2021 - 04/2018
2	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 03/2017
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021 - 01/2015
2	Interleukin-17 (Interleukin 17)IBA 03/2020 - 01/2013
2	VitaminsIBA 02/2018 - 01/2018
2	PyridoxalIBA 02/2018 - 01/2018
2	Vitamin B 6IBA 02/2018 - 01/2018
2	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 01/2015
2	Dextran SulfateIBA 01/2017 - 04/2016
2	Superoxide DismutaseIBA 01/2017 - 01/2013
2	Xanthine OxidaseIBA 01/2017 - 01/2013
2	SteroidsIBA 12/2016 - 11/2016
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2016 - 09/2015
2	Immunoglobulins (Immunoglobulin)IBA 02/2015 - 09/2009
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2015 - 11/2014
2	EnzymesIBA 01/2015 - 01/2013

Therapy/Procedure

18	Therapeutics 10/2022 - 04/2002
6	Endovascular Aneurysm Repair 08/2023 - 01/2014
5	Percutaneous Coronary Intervention 04/2013 - 07/2007
3	Catheter Ablation 01/2024 - 10/2022
3	Electrodes (Electrode) 01/2021 - 04/2015
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2014 - 11/2009
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2013
2	Tympanoplasty 11/2015 - 07/2014